Article
IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
The Journal of pathology - 1 Jul 2005
Cogliatti Sergio B, Bertoni Francesco, Zimmermann Dieter R, Henz Samuel, Diss Tim C, Ghielmini Michele, Schmid Ulrico
Abstract excerpt
Mantle cell lymphoma (MCL) is associated with a very unfavourable clinical course. This is particularly true for mantle cell lymphoma of the blastoid subtype (MCL-b). In order to define prognostic factors, we analysed the impact of immunoglobulin heavy chain variable (IgV H) gene somatic hypermutations on clinical outcome in a series of 21 cases of morphologically, phenotypically, and genotypically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
